Table 3 Baseline characteristics of participants according to FPG and HbA1c levels
|  | Group 1 normal FPG, normal HbA1c (n = 2619) | Group 2 normal FPG, impaired HbA1c (n = 974) | Group 3 impaired FPG, normal HbA1c (n = 595) | Group 4 impaired FPG, impaired HbA1c (n = 828) |
|---|---|---|---|---|
Age (year)a,‡ | 51.03 (9.73) | 56.79 (9.84) | 53.88 (9.15) | 56.42 (8.79) |
Male gender (%)b,‡ | 1678 (64.1) | 653 (67.3) | 482 (81.1) | 663 (80.3) |
FPG (mg/dl)a | 88.24 (7.49) | 91.0 (8.31) | 105.15 (5.05) | 107.24 (6.25) |
HbA1C %a | 5.2 (3.7) | 5.9 (3.7) | 5.3 (3.5) | 6.0 (3.6) |
BMI‡ | 25.26 | 26.15 | 26.50 | 27.21 |
SBP (mmHg)a,‡ | 117 (14) | 121 (15) | 123 (17) | 124 (16) |
DBP (mmHg)a | 72 (10) | 75 (10) | 76 (11) | 77 (10) |
Statin use (%)b | 75 (2.9) | 46 (4.7) | 18 (3.0) | 42 (5.1) |
Current smoker (%)b | 387 (14.8) | 163 (16.8) | 58 (9.8) | 121 (14.7) |
Physically active (%)b | 1995 (76.3) | 705 (72.8) | 425 (71.9) | 609 (74.2) |
LDL (mmole/l)a | 122 (27) | 122 (28) | 123 (26) | 121 (29) |
HDL (mmole/l)a,‡ | 52 (14) | 50 (13) | 47 (11) | 47 (11) |
Triglycerides (mmole/l)a, ‡ | 113 (64) | 123 (59) | 129 (66) | 137 (64) |